An 87-year-old man with a history of mild dementia on Aricept and hypertension on benazepril is brought to the emergency department by family after a possible fall.
A recent trial found that empagliflozin can reduce the risk of cardiovascular deaths in type 2 diabetes patients, but is that true for both men and women?
Pulmonary hypertension is a common complication of CHD but a new Danish study is the first to report on population-based incidence and impact.
Is there a relationship between osteoporosis, cardiovascular disease, and mortality? This new study aimed to find out.
Pulmonary arterial hypertension is often complicated by atrial arrhythmias; a new study sheds light on the clinical impact.
From fruit juice to fibrates to fluvastatin, what do you know about the safety of specific statin interactions?
Results of a subgroup analysis from the GRIPHON trial are promising for a hard-to-treat population.
Methamphetamine abuse is on a steady rise in the US. A new study highlights the nature and dangers of Meth-PAH.
Results of a new study suggest that stroke volume index may be the better hemodynamic variable to monitor in PAH – not cardiac index.
A new study finds that the first treatment chosen to treat PAH may help mitigate the burden of all-cause cost of care.